Sino Biopharma buys Hangzhou Hygieia Biomedical for up to $172m

Sino Biopharma buys Hangzhou Hygieia Biomedical for up to $172m

Illustration photo shows various medicine pills in their original packaging in Brussels, Belgium August 9, 2019. REUTERS/Yves Herman/Illustration

14 January, 2026

Hangzhou Hygieia Biomedical Sino Biopharmaceuticals

Printed by Unregistered user on Fri, 22 May 2026 17:30:16 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Sino Biopharmaceutical to acquire LaNova Medicines for up to $951m

Sino Biopharmaceutical to sell 67% stake in CP Qingdao for $253m

Read more from Greater China

China’s PCG Power may file for Hong Kong IPO by August

Venture Capital

China-focused BAI Capital holds first close of latest USD fund at $600m